Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166643 · ClinicalTrials.gov registry record · NA
Worksite Wellness Within Long-term Care Facilities
A NA study of Cardiovascular Diseases and Lifestyle Risk Reduction, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
- 1
- Study location
NCT04166643: Completed NA study of Cardiovascular Diseases and Lifestyle Risk Reduction, sponsored by University of Maryland, Baltimore.
NCT04166643 is a NA study of Cardiovascular Diseases and Lifestyle Risk Reduction that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 159 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04166643, a NA study of Cardiovascular Diseases and Lifestyle Risk Reduction, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposed study is to test the feasibility and preliminary efficacy of worksite wellness program designed to reduce worker stress (job and personal) and improve cardiovascular disease among long-term care workers. We also aim to test if increasing wellness behaviors in staff will translate to increased wellness behaviors in residents due to positive role modeling.
Primary Outcome
Composite life simple 7 scores and individual scores from life simple 7 components (blood pressure, weight, cholesterol, blood sugar, tobacco exposure, diet, physical activity) for staff
Conditions Studied
Interventions
- BEHAVIORAL Education only control
- BEHAVIORAL WHHIP PLUS
Study Locations (1)
Maryland
- University of Maryland School of Nursing - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2022-06-28 |
| Est. Completion | 2024-11-08 |
| Phase | NA |
What the finished NCT04166643 record still lists
NCT04166643 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Education only control is the first listed.
NCT04166643 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04166643 about?
NCT04166643 is a clinical study titled "Worksite Wellness Within Long-term Care Facilities". The goal of this proposed study is to test the feasibility and preliminary efficacy of worksite wellness program designed to reduce worker stress (job and personal) and improve cardiovascular disease among long-term care workers. We also aim to test if increasing wellness behaviors in staff will tra...
What is the current status of trial NCT04166643?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2022-06-28. Estimated completion is 2024-11-08.
What conditions does trial NCT04166643 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Lifestyle Risk Reduction, Occupational Stress, Worksite Health Promotion, Healthcare Workers.
What interventions are being tested in trial NCT04166643?
The interventions under investigation include: Education only control (BEHAVIORAL), WHHIP PLUS (BEHAVIORAL).
Who is sponsoring clinical trial NCT04166643?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04166643 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04166643's enrollment target sits among peer trials
159 168th of 300 higher than 133 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI